Rajatapiti, P and van der Horst, IWJM and de Rooij, JD and Tran, MGB and Maxwell, PH and Tibboel, D and Rottier, R and de Krijger, RR (2008) Expression of hypoxia-inducible factors in normal human lung development. PEDIATR DEVEL PATHOL , 11 (3) 193 - 199. 10.2350/07-04-0257.1.
Full text not available from this repository.
Pulmonary vascular development is essential for proper lung development, and its disturbance can lead to neonatal morbidity and mortality, as exemplified in congenital diaphragmatic hernia. Hypoxia-inducible factors (HIFs) appear to be key molecules in physiologic angiogenesis and in certain forms of lung pathology, such as bronchopulmonary dysplasia. Little is known about the qualitative and quantitative expression of HIFs in normal human fetal lung development. Therefore, we investigated the expression of HIT-1 alpha, HIF-2 alpha, and HIF-3 alpha, along with their upstream regulators and downstream targets, von Hippel-Lindau protein, vascular endothelial growth factor A (VEGF-A), and its receptor, VEGFR-2, in 20 normal human fetal lungs (13.5 weeks in gestation until term) and 5 adult lungs. Quantitative polymerase chain reaction demonstrated a positive correlation between HIF-2 alpha and VEGF-A expression and gestational age. Although there appeared to be a decreasing trend in HIF-3 alpha expression during pregnancy, it did not reach statistical significance. Immunohistochemistry for HIF-1 alpha and HIF-2 alpha revealed that HIF-1 alpha is expressed in the epithelium, while HIF-2 alpha is expressed in both interstitium and epithelium. Our data indicate that HlFs, most notably HIF-2 alpha, appear to exert an important role in angiogenesis during human fetal lung development, especially in the last phases of pregnancy, preparing the fetus for extrauterine life. As such, our results form the baseline data for the evaluation and interpretation of abnormal pulmonary vascular development.
|Title:||Expression of hypoxia-inducible factors in normal human lung development|
|Keywords:||hypoxia-inducible factor, lung development, vascular endothelial growth factor, ENDOTHELIAL GROWTH-FACTOR, PAS DOMAIN PROTEIN, BRANCHING MORPHOGENESIS, EMBRYONIC-DEVELOPMENT, VASCULAR DEVELOPMENT, CELL-PROLIFERATION, GENE-EXPRESSION, VEGF, HIF-2-ALPHA, ANGIOGENESIS|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)|
Archive Staff Only: edit this record